PHARMACY

Cardinal Health introduces new tool to help mail-order pharmacies improve efficiency, lower costs

BY Allison Cerra

DUBLIN, Ohio Cardinal Health recently introduced a new service that helps mail-order pharmacies remove significant inefficiencies and unnecessary costs from the process of receiving and replenishing pharmaceutical products.

Cardinal Health’s new, patent-pending EZ Cart system addresses key supply chain ‘pain points’ by dramatically simplifying process mail-order pharmacies use to replenish and manage pharmaceutical products, the company said. Developed in collaboration with its mail-order customers, the program streamlines this process by presorting pharmaceutical products into compartmentalized containers which are then placed into plastic bins. These bins are then placed onto mobile carts, organized by assigned locations at each customer site – before they arrive at the customer’s loading dock. Mail-order pharmacies simply remove the carts from Cardinal Health delivery trucks and wheel them directly to the specific location within their facility where product is stored; eliminating multiple steps from the process of receiving and replenishing pharmaceutical products.

“Cardinal Health’s new EZ Cart program helps our mail-order customers improve their overall efficiency by streamlining the way they receive products and by freeing up their time to focus on meeting the needs of their members and clients,” said Law Burks, VP marketing management for Cardinal Health’s Alternate Care business. “By partnering with our customers to identify and create innovative solutions to key supply chain pain points like this, Cardinal Health continues to deliver on its commitment to improve the cost-effectiveness of health care.”

Key customer benefits that EZ Cart delivers include:

  • Labor savings of up to 35-40% per receiving-and-inventory-replenishment employee, allowing participating companies to reallocate staffing resources to other critical tasks
  • Fewer inventory ‘stock outs’ and increased fill rates because products get more quickly from the receiving dock to the location where they are stored
  • Increased security due to EZ Cart doors being secured with numbered seals
  • Easier maneuverability within facility and less physical strain on employees when using the EZ Cart compared to receiving products on a pallets.

To learn more about EZ Cart and other services that Cardinal Health offers to help its mail-order customers improve cost-effectiveness, visit www.cardinalhealth.com/mailorder.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

CAORC to host press briefing on organized retail crime

BY Alaric DeArment

WASHINGTON When most people think of organized crime, they imagine gun battles in the streets of Chicago during the Prohibition era, but some of its biggest victims are retail pharmacies.

The Coalition Against Organized Retail Crime announced that it would have a press conference at noon on Wednesday to discuss the role of federal law enforcement in combating organized retail crime. The conference will take place before a hearing of the House Judiciary Committee Subcommittee on Crime, Terrorism and Homeland Security on the subject.

Organized retail crime involves the theft of large quantities of goods from retailers and the sale of those goods through pawn shops, flea markets and online. It causes losses of tens of billions of dollars annually and puts consumers at risk of using mishandled and adulterated goods.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

FDA rejects expanded use of Pegintron

BY Alaric DeArment

KENILWORTH, N.J. The Food and Drug Administration has rejected an approval application for an additional use for a hepatitis C drug.

Schering-Plough Corp. announced Friday that it had received a complete response letter – an FDA notice of rejection – for Pegintron (pegylated interferon alfa-2b) as a treatment for stage 3 malignant melanoma. The FDA’s Oncologic Drugs Advisory Committee had recommended approval of the drug for the disease by vote of 6 to 4 in October.

Schering-Plough said it would work with the FDA to respond to the agency’s concerns. The drug is already approved for treating chronic hepatitis C in combination with Schering-Plough’s Rebetol (ribavarin).

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?